These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 16045558

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.
    Lehrer S, Diamond EJ, Stagger S, Stone NN, Stock RG.
    Br J Cancer; 2002 Sep 23; 87(7):726-8. PubMed ID: 12232754
    [Abstract] [Full Text] [Related]

  • 3. Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
    Tsurusaki T, Koji T, Sakai H, Kanetake H, Saito Y.
    Clin Cancer Res; 1998 Sep 23; 4(9):2187-94. PubMed ID: 9748138
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
    Fujita K, Denda K, Yamamoto M, Matsumoto T, Fujime M, Irimura T.
    Br J Cancer; 1999 Apr 23; 80(1-2):301-8. PubMed ID: 10390012
    [Abstract] [Full Text] [Related]

  • 6. Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy.
    Okegawa T, Kinjo M, Nutahara K, Higashihara E.
    Int J Urol; 2006 Sep 23; 13(9):1197-201. PubMed ID: 16984552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
    Takayama H, Nonomura N, Nishimura K, Oka D, Shiba M, Nakai Y, Nakayama M, Tsujimura A, Aozasa K, Okuyama A.
    BJU Int; 2009 Feb 23; 103(4):470-4. PubMed ID: 18778349
    [Abstract] [Full Text] [Related]

  • 10. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer.
    Ohno T, Aihara R, Kamiyama Y, Mochiki E, Asao T, Kuwano H.
    Eur J Cancer; 2006 Jan 23; 42(2):256-63. PubMed ID: 16356709
    [Abstract] [Full Text] [Related]

  • 11. Expression of MUC1, MUC2 and oligosaccharide epitopes in breast cancer: prognostic significance of a sialylated MUC1 epitope.
    Baldus SE, Wienand JR, Werner JP, Landsberg S, Drebber U, Hanisch FG, Dienes HP.
    Int J Oncol; 2005 Nov 23; 27(5):1289-97. PubMed ID: 16211224
    [Abstract] [Full Text] [Related]

  • 12. Expression of MUC1 mucins in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder.
    Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T, Kano M, Koike N, Fukao K, Tanaka N, Todoroki T.
    Clin Cancer Res; 2001 May 23; 7(5):1333-42. PubMed ID: 11350903
    [Abstract] [Full Text] [Related]

  • 13. Characterization of MUC1 glycoprotein on prostate cancer for selection of targeting molecules.
    Burke PA, Gregg JP, Bakhtiar B, Beckett LA, Denardo GL, Albrecht H, De Vere White RW, De Nardo SJ.
    Int J Oncol; 2006 Jul 23; 29(1):49-55. PubMed ID: 16773184
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Factors influencing the progression-free survival time of prostate cancer patients after endocrine therapy].
    Guan YB, Zhang YF, Wen H, Zhou SQ, Dai YT.
    Zhonghua Nan Ke Xue; 2009 Sep 23; 15(9):801-5. PubMed ID: 19947562
    [Abstract] [Full Text] [Related]

  • 16. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
    Zhigang Z, Wenlu S.
    Prostate; 2007 May 01; 67(6):653-60. PubMed ID: 17342746
    [Abstract] [Full Text] [Related]

  • 17. Prostate-specific antigen velocity and prostate cancer gleason grade and stage.
    Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK.
    Cancer; 2007 Apr 15; 109(8):1689-95. PubMed ID: 17330856
    [Abstract] [Full Text] [Related]

  • 18. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
    Zhigang Z, Wenlv S.
    Jpn J Clin Oncol; 2004 Jul 15; 34(7):414-9. PubMed ID: 15342669
    [Abstract] [Full Text] [Related]

  • 19. Elevated serum progastrin-releasing peptide (31-98) level is a predictor of short response duration after hormonal therapy in metastatic prostate cancer.
    Yashi M, Nukui A, Kurokawa S, Ochi M, Ishikawa S, Goto K, Kobayashi Y, Muraishi O, Tokue A.
    Prostate; 2003 Sep 01; 56(4):305-12. PubMed ID: 12858359
    [Abstract] [Full Text] [Related]

  • 20. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 01; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.